Substantial Shareholder Ups Stake in Australian Clinical Labs

Australian Clinical Labs Ltd (AU:ACL) has released an update.

Australian Clinical Labs Ltd has experienced a change in the interests of substantial holder Yarra Capital Management and its associated entities, with their voting power increasing from 5.30% to 6.34% between October 2023 and August 2024. The change occurred through acquisitions and disposals with a total consideration of over $7.9 million affecting over 2.9 million shares. No new associates have been reported in relation to the voting interests of the company.

For further insights into AU:ACL stock, check out TipRanks’ Stock Analysis page.